Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma

Abstract Background Nivolumab is used for the treatment of malignant pleural mesothelioma (MPM). However, immune-related adverse events (irAEs) occur in patients treated with nivolumab. Several studies have reported the correlation between irAEs and therapeutic effects of immune checkpoint inhibitor...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Hirokazu Ogino, Kenji Otsuka, Yasuhiko Nishioka
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Immune-related adverse events Malignant pleural mesothelioma Nivolumab Therapeutic effect Diseases of the respiratory system RC705-779
Acceso en línea:	https://doaj.org/article/283e2c804e1e4caca2a024bc86d5df46
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma

Ejemplares similares